stockportfolio.pro
Stocks / BRKR vs QGEN
BRKR vs QGEN
Bruker Corporation and Qiagen N.V. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Bruker Corporation (BRKR) | Qiagen N.V. (QGEN) | |
|---|---|---|
| Market cap | $8.4B | $7.6B |
| Revenue (latest FY) | $3.44B | $2.09B |
| Net income (latest FY) | $-22.50M | $424.88M |
| Revenue growth (5y CAGR) | 11.6% | -0.8% |
| Net margin | -0.7% | 20.3% |
| Return on equity | -0.9% | 11.2% |
| P/E ratio | — | 18.8 |
| Dividend yield | 0.3% | 0.9% |
| Profitable years (of last 10) | 9 | 4 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BRKR — free Open QGEN — freeFrequently asked questions
Which is bigger, BRKR or QGEN?
Bruker Corporation is larger by market capitalization — $8.4B versus $7.6B.
Which grows faster, BRKR or QGEN?
Over the last five fiscal years, Bruker Corporation grew revenue faster — 11.6%/yr versus -0.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.